Consumer products company Colgate-Palmolive (NYSE:CL) met Wall Street’s revenue expectations in Q3 CY2024, with sales up 2.4% year on year to $5.03 billion. Its non-GAAP profit of $0.91 per ...
In a report released yesterday, Andrea Faria Teixeira from J.P. Morgan maintained a Buy rating on Colgate-Palmolive (CL – Research Report), with a price target of $109.00. Andrea Faria Teixeira ...
Wall Street expects a year-over-year increase in earnings on higher revenues when Colgate-Palmolive (CL) reports results for the quarter ended September 2024. While this widely-known consensus ...
In a new SEC filing on November 5, it was revealed that III, Chief Financial Officer at Colgate-Palmolive (NYSE:CL), executed a significant exercise of company stock options. What Happened ...
If you worry about flu shot ingredients, you should know that they have a decades-long history of safety. With only a few exceptions, such as a rare allergy to one of the ingredients, flu vaccines are ...
Metaphor ReFantazio lets you cook many dishes that can efficiently assist you throughout your adventure in the title. You can use the Cooking Table to produce various items as you advance through ...
Shares of Colgate-Palmolive Inc. reversed into the red premarket Friday, after the toothpaste and toothbrush giant beat third-quarter earnings expectations, but saw relative weakness in North ...
FMCG major Colgate-Palmolive India sank almost five percent into the red during the early session on October 25, as the Street digested the toothpaste maker's earnings show for the quarter ended ...